progenitor cell; pericyte; CXCR4; CD24 THE HISTOLOGICAL LESION OF ACUTE tubular injury (ATI), which is characterized by cell necrosis or apoptosis and subsequent sloughing of injured tubular epithelial cells, is the hallmark finding on kidney biopsy in patients with intrinsic acute kidney injury (AKI). AKI is a common disease in the hospital setting and contributes to significant morbidity and mortality, especially in the elderly population. Understanding the molecular mechanisms of ATI and the subsequent epithelial cell regeneration process, offers possible new therapeutic avenues for the treatment of AKI. Several studies conducted in ischemiareperfusion tubular injury models have shown that tubular epithelial cells become mitotically active and dedifferentiate before the regeneration phase of ATI (48, 51) . This process induces the reactivation of some of the developmental genes involved in nephrogenesis (48) . Tubular injury repair further involves epithelial cell proliferation and migration of adjacent surviving cells to repopulate denuded basement membranes (3, 45) . A variety of growth factors, cytokines, and other inflammatory mediators regulate this repair process (4, 5, 43) . However, the regulatory cells and mechanisms that guide and conduct this repair process are still enigmatic.
Several recent studies have elucidated the origin of the proliferating cells involved in tubular injury repair (19, 20) . Using genetic lineage analysis, Humphreys et al. (20) showed that tubular cell repair after ischemic injury does not involve replacement of injured cell by extra tubular stem cells. Moreover, they showed in a different study that the proximal tubule does not contain intratubular progenitor cells (19) . A celltherapy model in rats has shown the beneficiary effect of injected bone marrow-derived mesenchymal stem cells (MSCs) on tubular epithelial injury repair following ischemiareperfusion injury (46) . The stimulatory effect on tubular cell regeneration may be mediated through paracrine factors expressed by the injected MSCs (47) . However, Duffield et al. (14) studied kidney repair in chimeric mice and showed that only a minor percentage of tubule cells were bone marrow derived after ischemic injury and repair. These findings suggest that tubular injury repair is mediated through paracrine effects that stimulate proliferation of the residual tubular epithelium and that intrinsic progenitor cells might play an important role in this process.
Renal intrinsic progenitor cells have been identified in several compartments of the kidney, including glomeruli, peritubular capillaries, and the medullary interstitium (34, 38) . Several recent studies show evidence that the renal medulla harbors intrinsic progenitor cells that may be involved in tubular injury regeneration (10, 21) . The isolation of pluripotent renal progenitor cells from the adult rat kidney has been described (15) . These progenitor cells expressed CD44, Pax2, and there is evidence that renal progenitor cells may contribute to repair of ATI (39) . However, the mechanisms of medullary progenitor cell (MPC) activation and the cytokines expressed and released by these cells during repair of ATI are still poorly understood (53) .
In this study, we have isolated an MPC side population from a primary medullary interstitial cell line. We show that the MPCs strongly express CD24, CD44, CXCR7, CXCR4, nestin, and PAX7. Importantly, MPCs were CD34 negative, indicating that they are not bone marrow-derived. MPCs survived Ͼ50 passages and when grown in epithelial differentiation medium, developed phenotypic characteristics of epithelial cells. Inner medulla collecting duct (IMCD3) cells, treated with conditioned medium from progenitor cells showed significantly accelerated wound healing. Moreover, conditioned medium from progenitor cells induced tubulogenesis in IMCD3 cells. Our study shows that the medullary interstitium harbors a side population of progenitor cells that can differentiate to epithelial cells and can improve tubular epithelial cell wound closure.
Moreover, most of the MPCs express PDGFR-b, suggesting that they are pericytes, which induce proliferation and migration of tubular epithelial cells. Our study suggests that medullary pericyte/progenitor cells may play a critical role in reepithelialization of medullary tubular epithelial wounds following injury.
MATERIALS AND METHODS
Cell culture and selective growth conditions. Mouse medullary interstitial cell (MMIC) primary cultures were generated from C57bL/6 mice as described previously (29, 30) . Briefly, kidneys were removed under aseptic conditions from five of six genetically identical mice, and the medulla was dissected, minced into 1-mm fragments, and passed through a small meshed sieve by hand into 5 ml of tissue culture media. The cell suspension was then centrifuged, and the pellet was suspended in KRB buffer containing antibiotics (30). The cell suspension was then injected under anesthesia at four to six different locations intraperitoneally into the sixth mouse. Three days after injection, small intraperitoneal nodules were harvested under aseptic conditions, minced, and plated out on 100-mm cell culture dishes in DMEM (GIBCO, Carlsbad, CA). The cells were stained with oil red O after three to four passages to confirm the characteristic cytoplasmic lipid vacuoles of medullary interstitial cells. All animal experiments were approved by the Institutional Animal Care and Use Committee at Yale University. For the selective growth experiments, cells were plated in either DMEM (medium A, Table 1 ), in DMEM/ F12 (GIBCO; medium B, Table 1 ), or in the above buffers supplemented with knockout serum replacement (KSR; mediums C and D; see Table 1 ). All buffers were held serum free since FBS contains factors that may cause unwanted cell differentiation (17) . Therefore, KSR was used as a defined serum-free replacement since it has been shown in several experiments to increase proliferation as well as improve chimerism in mouse embryonic stem cell lines (11) . Some cells were also cultured in the above base buffers supplemented with N-2 (1ϫ) supplement (mediums E and F; see Table 1 , Invitrogen, Carlsbad, CA). The N-2 media supplement has been shown in several studies to enhance expansion and be necessary for the maintenance and differentiation of stem/progenitor cells (13, 49) . Both hyperosmotic and hypoxic conditions were tested to mimic the cell growth conditions of the renal medulla (8, 31) . Hypertonic culture conditions were achieved by addition of 12.9 l of a 5 M NaCl stock solution and adjusting the final medium osmolality to 400 mosmol/kgH 2O. Hypoxic conditions were established by culturing cells in the base buffers in 1% O2, 5% CO2, and 94% N2. All other cells were incubated in 95% air, 5% CO2 humidified atmosphere at 37°C.
For the cell differentiation experiments, the following growth media were used: MEM Alpha (12571-063; GIBCO) with 1ϫ insulintransferrin-selenium (ITS; catalog 41400-045; GIBCO), containing 2% FBS. This was mixed 1:1 with either endothelium growth medium (catalog no. CC4147; LONZA; 2% FBS; 0.04% hydrocortisone; 0.4% hFGF-B; 0.1% VEGF; 0.1% R3-IGF-1; 0.1% ascorbic acid; 0.1% hEGF, 0.1% GA) or with epithelial growth medium (RenaLife medium Complete Kit, LifeLine no. LL-0025).
Immunofluorescence staining. Cells were seeded on chamber slides (BD Falcon, Bedford, MA) at a density of 4 ϫ 10 3 /well in their respective cultured medium for 3 days. Cells were fixed in 4% phosphate-buffered paraformaldehyde (pH 7.4). Triton X-100 (0.1%) was used to render the cells permeable followed by blocking solution with 5% normal goat serum and 1% BSA. Cells were then incubated overnight at 4°C with antibodies directed against the following stem cell markers: CXCR4 (ab1670; Abcam, Cambridge, MA), CXCR7 (ab72100; Abcam), CD24 (ab31622; Abcam), CD34 (ab8158; Abcam), rat-CD44 (no. 18849; Santa Cruz Biotechnology, Dallas, TX), rabbit CD-44 (7946; Santa Cruz Biotechnology), nestin (no. 556309, BD Bioscience, San Jose, CA), CD133 (no. 4310; Millipore), and Pax-7 (ab34360; Abcam). Cells were then incubated with fluoresceinconjugated secondary antibodies (Vector Laboratories, Burlingame, CA) for 2 h. Cells were stained for actin filaments with rhodamine phalloidin (Invitrogen, Eugene, OR) for 15-30 min. Cell nuclei were stained with 4,6-diamidino-2-phenylindole. Slides were examined using a Zeiss Axiophot inverted fluorescence microscope. Images were obtained and processed using MagnaFire 2.1C software (Olympus, Melville, NY) and ImageJ software (National Institutes of Health, Bethesda, MD). Cells with positive expression of respective stem cell marker were quantified in five randomly picked high-power (ϫ200 
magnification) fields using the point-counting method (35) . Assays were performed at least in triplicate; error bars represent SE.
Cell proliferation assay. Cell proliferation rates were assessed by the mitochondrial-dependent reduction of MTT (M-2128, Sigma, St. Louis, MO) to purple formazan. After overnight culture in a 96-well plates, kidney fibroblasts (NRK-49F; 1 ϫ 10 4 cells/well) were treated either with the original growth medium or with 50% or 100% MMICs-derived, conditioned medium. After 48 h of treatment with conditioned medium, 20 ul of 5 mg/ml MTT solution (100 g/well) were added for an additional 2 h. The medium was then removed and resuspended with formazan (MTT metabolic product) in 200 l isopropanol. Specimens were placed on a shaking plate at medium speed for 5 min until all crystals were dissolved. Absorbance at 550 nm was measured using a microplate reader (model 3550; Bio-Rad, Hercules, CA).
Wound healing assay. IMCD3 cells (CRL no. 2123, ATCC) were plated (80,000 cells/well) in a 24-well Image Lock Plate (Essen Bioscience, Ann Arbor, MI). After 24 h, 100% confluent cells were wounded using a semimanual wound-maker tool, and then cells were cultured in either DMEM or progenitor cell-conditioned medium (CM), which had been collected from selectively grown progenitor cell culture. Images and measurements of the wound were taken every hour for up to 18 h after wound initiation. Changes in wound width were calculated in imaging plates using the Incucyte system (Essen Instruments), applying around-the-clock kinetic imaging.
Tubulogenesis assay. Assays to assess tubulogenesis were performed using IMCD3 cells in three-dimensional (3D) ECM gels as described previously (40) . Collagen gels were composed of 0.1 mg/ml collagen I in DMEM containing 20 mM HEPES (pH 7.2). One hundred microliters of medium supplemented with 10% FCS or conditioned medium were added to the gels after they had solidified.
For quantification of the branches, cells that formed branching structures (defined as Ͼ1 branch) were counted in five randomly picked high-power fields. Image analysis was performed using a Zeiss Axiophot fluorescence microscope (Jena, Germany). The degree of branching morphogenesis was quantified by using the number of end points as a correlative measure of the number of branching events. Assays were performed at a minimum in triplicate; error bars represent SE.
Western blot analysis. IMCD3 cells were grown in six-well plates (10 ϫ 10 4 cells/well) for 48 h and then treated with either original growth medium, original growth mediumϩ50% CM or with 100% CM from MMICs for 48 h. Cell samples were then prepared using RIPA buffer (Boston Bioproducts, Worcester, MA) containing protease inhibitors, 1 mM NaF, and 2 mM Na 3VO4. The protein concentration was determined using the bicinchoninic acid method (Pierce Pharmaceuticals, Rockford, IL). Ten micrograms of cell lysates in sample loading buffer were electrophoresed on 10% SDS-PAGE minigels under denaturing conditions. After being transferred onto a nitrocellulose membrane, the membranes were incubated with blocking solution for 2 h at room temperature and hybridized overnight with rabbit polyclonal anti-proliferating cell nuclear antigen (PCNA; SC-56; Santa Cruz Biotechnology) antibody or mouse monoclonal anti-␤-actin antibody (A2228; Sigma-Aldrich) in blocking buffer at 4°C. The membrane was then incubated with horseradish peroxidase-conjugated secondary antibody diluted 1:3,500 for 60 min at room temperature. The detection of specific signals was performed using the enhanced chemiluminescence method (Amersham, Buckinghamshire, UK).
Statistical analysis. All data are presented as means Ϯ SE. Statistical analysis used Student's t-test for pairs with the following significance levels: *P Ͻ 0.05. All figures were generated from at least three repeated experiments with similar patterns.
RESULTS
MMIC characteristics. Primary cultures of MMICs showed a homogenous population of cells with Ͼ96% of cells displaying the classic medullary interstitial cell features of abundant oil red O-positive cytoplasmic lipid droplets and elongated cytoplasmic extensions (Figs. 1A and Fig. 2 ), which have been described previously (29) . Additional immunofluorescence studies showed expression of ␣-smooth muscle actin (SMA; Fig. 1B), vimentin (Fig. 1C) , and cyclooxygenase (COX) 2 (Fig. 1D ) in nearly all of the medullary interstitial cells (MICs). Together, the above cytological features and the expressed protein patterns are consistent with a homogenous MIC population in our preparation (16, 36, 44) . Selective growth of a kidney MPC population. To determine the optimal culture conditions and selective growth conditions to isolate the progenitor cell subpopulation from the MIC population, primary cell cultures were plated in a 24-well plate and treated in the selective growth culture medium. Cells grown in DMEM (medium A, Table 1 ) typically maintained interstitial cell morphology throughout the period of observation and did not show high percentages of CXCR4ϩ cells after four passages (Table 2 ). Primary cells cultured in medium supplemented with 10% KSR (medium C or D, Table 1) showed a significant increase in the number of CXCR4ϩ cells with typical stem cell morphology compared with the cells cultured in medium A or B (Table 2, Fig. 3) . A further increase in CXCR4ϩ progenitor cells was seen in cultures with selective media supplemented with 10% KSR plus N2 (mediums E and F, Table 1 ). Of the cells cultured in mediums E or F, 56 and 90%, respectively, showed stem cell morphology and CXCR4 positivity (Table 2) . Moreover, these cells were cultured for Ͼ50 passages without significant loss of progenitor marker expression.
Characteristics of MPCs. A selectively grown subpopulation of cells, which showed positive expression of six different progenitor cell markers, was generated from MMIC primary cultures. This subpopulation showed positive expression for CXCR4, CXCR7, CD24, nestin, Pax7, and CD44 (see Table 3 , Figs. 4 and 5) . IMCD control cells did not stain for the respective progenitor cell marker ( Fig. 6 and 7) . The percentage of cells expressing CXCR4 and CXCR7 increased from 11 and 10% in nonselective growth media to 90 and 56%, respectively, when cultured in DMEM supplemented with KSR and N2 ( Table 3 , Fig. 8 ). Of selectively grown progenitor cells, 69% showed positive expression for CD24, a marker associated with progenitor cell characteristics in the kidneys (1) (Figs. 4B and 8, Table 3 ). Moreover, 43% of selectively grown progenitor cells showed positive nestin expression, a known marker in kidney stem cells (Figs. 5A and Fig. 8, Table 3 ) (52). Pax7, a skeletal muscle stem cell marker (6), was positively expressed in 77% of selectively grown progenitor cells (Fig.  5B, Table 3 ). Interestingly, none of the selectively grown progenitor cells showed CD34 expression (Fig. 5D) , which is highly expressed on hematopoietic pluripotent stem cells (26) (Fig. 4) . Furthermore, selectively grown progenitor cells showed expression of the pericyte marker PDGFR-b (Figs. 4D and 8) .
Effect of MPC media on IMCD cell viability and proliferation. IMCD cells (IMCD3) were exposed to CM from progenitor cell cultures for 48 h. Cell survival was markedly increased in CM-treated IMCD3 cells compared with control cells grown in DMEM (Fig. 9A ). Western blot analysis shows that there was increased PCNA abundance with increasing concentrations of CM. There was a visible increase in the expression of PCNA in cells treated with 100% CM compared with DMEM control (Fig. 9B) . These results indicate that MPCs release soluble factors that enhance cell proliferation and survival.
Effect of MPCs on wound repair. IMCD3 cells treated with CM from enhanced progenitor cultures showed increased rates of wound healing (Fig. 10, A and B) . During the first 6 h of IMCD growth in CM, a significant decrease in wound width was seen compared with cells in control medium. Relative to their respective 0-h wound width, IMCD3 cells grown in DMEM for 6 h showed only a 30% decrease in wound width, while the IMCD3 cells grown in CM for 6 h showed a 47% decrease in wound width. This trend in wound reduction continued further in IMCD3 cells grown in CM, which showed a 77% reduction in wound width after 10 h and 100% reduction after 17 h (Fig. 10B) . Cells grown in DMEM for the same time showed reductions in wound width by only 50%.
Effect of MPCs on endothelial and epithelial differentiation. Selectively grown MPCs were cultured in renal epithelial growth medium (RenaLife Medium Complete Kit, LifeLine) for 7 wk. Throughout this growth period, these progenitor cells developed an epithelial cell-like phenotype, characterized by a dense, adherent cuboidal monolayer (Fig. 11, A  and B) . These differentiated cells expressed the pan-cytokeratin cell markers AE1/AE3 (Fig. 11C ). MPCs were also grown in endothelial growth medium (EGM-2 MV, Lonza) for 7 wk (Fig. 11, D and E) . Progenitor cells in this experiment developed a more loose arrangement of oblong and rounded cell layers without well-defined cell-cell junctions, more closely resembling an endothelial-type phenotype (Fig. 11, D and E) and showed weak expression of the endothelial marker CD31 (Fig. 11F) . (Fig. 12A) . Follicular progenitor cells were used as positive controls for CD34 (Fig. 13) .
Effect of CM from

DISCUSSION
This study is aimed at characterizing a medullary interstitial progenitor cell population and assess its effect on epithelial cell wound closure. We show that the medullary interstitium harbors a side population of kidney progenitor cells that can differentiate into epithelial cells, can induce tubulogenesis in cultured medullary collecting duct cells, and can mediate tubular epithelial cell migration and proliferation. We conclude from these studies that a medullary interstitial progenitor cell population exists that can repair injured medullary collecting duct cells. Preparation of a medullary interstitial primary cell culture generated a highly purified MIC population that showed characteristic elongated cytoplasmic extensions, oil red O-positive cytoplasmic granules, and positive ␣-SMA, vimentin, and COX2 expression. These characteristics have previously been observed in several studies and are consistent with MICs (16, 29, 36, 44) .
When MIC primary cultures were grown for an extended period in selective knockout buffer (KSR plus N2), a cell population emerged that expressed several known progenitor/ stem cell markers. Notably, nestin, PAX7, CD44, CXCR4, CXCR7, and CD24 were strongly expressed. They also expressed weak OCT4 (data not shown). These MPCs were negative for the hematopoietic stem cell marker CD34. The marker profile seen in our MPCs correlates with previously shown kidney progenitor cell profiles (32, 41, 50) . It is possible that our MPCs are similar to the mouse kidney progenitor cell (MKPC) population previously isolated from Myh9-targeted mutant mice, which were also OCT4 positive and CD34 negative (25) . Our MPCs also strongly expressed PDGFR-b, suggesting that they are pericytes. This is consistent with previously published data on MPCs that were injected into SCID mice and localized close to the medullary vasculature (25) . These findings indicate that many of the MPCs are pericytes or have some transdifferentiation toward a pericyte phenotype.
Stromal-derived factor-1 (SDF-1) is a regulator of mobilization and migration of endothelial progenitor cells (24) . SDF-1 is the ligand of important chemokine receptors CXCR4 and CXCR7 (9, 23) . Both CXCR4 and CXCR7 have been shown to play vital roles in tissue regeneration and renal function improvement as well as being required for transendothelial migration (28) . The SDF-1/CXCR4 axis is involved in papillary label-retaining cell (LRC) activation after AKI (33) . The presence of both chemokine receptors on our MPCs indicates a possible role of SDF-1 as a local mediator in the epithelial cell trans-differentiation of MPCs. Moreover, SDF-1 and its receptors have been shown to enhance progenitor cell survival (28) . This indicates that SDF-1 may mediate survival of MPCs, enhancing their possible role in tubular epithelial cell regeneration after injury. Kidney progenitor cells repair tubular injury predominantly through paracrine effects (18) . Therefore, we tested the impact of CM from MPCs on IMCD3 cell proliferation and migration. We found that CM treatment enhances proliferation and migration of IMCD3 cells. These findings are consistent with the hypothesis that MPCs stimulate proliferation of tubular epithelial cells following injury (19, 27) . Paracrine actions have been implicated as predominant modality how mesenchymal stem cells mediate their effect on cell trans-differentiation and tubular injury repair in rat kidneys with AKI (47) . Kidney progenitor cells have previously been isolated from rat and mouse kidneys (12, 15) . Injection of these progenitor cells into injured kidneys did show a beneficial effect on renal function, even without their integration into injured nephron segments (12) . However, the paracrine factors secreted by progenitor cells in AKI are still enigmatic, and the mechanisms through which these enhance tubular injury repair remain to be shown.
Progenitor cells are characteristically committed to differentiation toward a specific phenotype (2, 37) . We therefore grew MPCs in epithelial and endothelial differentiation media to stimulate their development along either one of these cell lineages. We found that MPCs grown in epithelial differentiation medium showed significant expression of the pan-cytokeratin marker AE1/AE3, indicating that MPCs can differentiate to epithelial cells. However, we could not observe significant differentiation to an endothelial phenotype. Our results differ from those published by Lee et al. (25) that showed mouse kidney progenitor cell differentiation to an endothelial phenotype in vivo. A possible explanation is that they isolated a slightly different subpopulation of MPCs, which still has the potential for endothelial differentiation in vivo.
To examine whether MPCs secreted factors that enhance tubule formation, we treated IMCD3 cells that were grown in 3D Matrigel with CM from PGE 2 -treated MPCs, which induced growth of tubule-like structures. That was not seen when IMCD3 cells were treated with control medium or with CM from TGF-␤-treated MPCs. We conclude from these results that MPCs secrete factors that stimulate tubule formation in medullary collecting duct cells. Moreover, PGE 2 might play an important role as an autocrine factor inducing cytokine release from MPCs that then act as paracrine effectors to stimulate tubular epithelial cell migration and proliferation. In summary, our results show that the renal medullary interstitium harbors a side population of cells with progenitor cell characteristics. These cells positively affect medullary collecting duct cell proliferation and migration. Previous studies have indicated that the inner medulla harbors stem cells with regenerative potential (34) . Diseases associated with papillary necrosis have been shown to develop progressive chronic kidney disease and end-stage renal disease (22, 42) , which may be due to the loss of MPCs. Supporting the importance of MPCs in kidney injury repair is the observation in animal models of mercuric chloride-induced AKI, showing induction of cell proliferation in the papillary region of the kidney, which likely represents a repair response by MPCs (7) . MPCs may after all play an important role in the repair of tubular epithelial cell injury, likely through paracrine-mediated mechanisms.
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